Web Analytics

3 Latest Announced Rounds

  • $20,000,000
    Series A

    5 Investors

    Technology, Information and Internet
    Jan 16th, 2026
  • $5,400,000
    Unknown

    1 Investors

    Security & Investigations
    Jan 16th, 2026
  • $30,000,000
    Series C

    3 Investors

    Semiconductor Manufacturing
    Jan 16th, 2026
$2,375.16M Raised in 64 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Trogenix

start up
United Kingdom - Edinburgh, Scotland
  • 07/10/2025
  • Series A
  • $94,323,600

Precision genetic medicines, engineered for change


Related People

Ken MacnamaraFounder

Ken Macnamara United Kingdom - Greater Edinburgh Area

Ken is the Chief Executive Officer of Trogenix, a biotech uniting cutting-edge technologies in genomics, oncology, immunotherapy, and gene therapy to create a revolutionary therapeutic approach.